XML 66 R49.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Royalty and Commercial Payment Purchase Agreements - Dare (Details) - USD ($) $ in Thousands |  | 6 Months Ended |
--- | --- | --- | ---
Apr. 29, 2024 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023
Agreements |  |  |  |
Payments of consideration under RPAs, AAAs and CPPAs |  | $ 37,000 | $ 14,650 |
Receipts under RPAs, AAAs and CPPAs |  | 16,741 | $ 2,934 |
Long-term royalty and commercial payment receivables |  | 69,731 |  | $ 57,952
Short-term royalty and commercial payment receivables |  | 14,257 |  | $ 14,215
Royalty Purchase Agreement | Dare |  |  |  |
Agreements |  |  |  |
Payments of consideration under RPAs, AAAs and CPPAs | $ 22,000 | 22,000 |  |
Percentage of remaining royalties | 100.00% |  |  |
Payable on milestone | $ 11,000 |  |  |
Specified amount of each successive receipt that requires milestone payment | 22,000 |  |  |
Return threshold | $ 88,000 |  |  |
Short-term royalty and commercial payment receivables |  | 0 |  |
Amount of allowance for credit losses |  | $ 0 |  |
Royalty Purchase Agreement | Dare | OVAPRENE |  |  |  |
Agreements |  |  |  |
Royalties entity has right to receive (as a percent) | 4.00% |  |  |
Royalty Purchase Agreement | Dare | OVAPRENE | Upon achievement of a pre-specified return threshold |  |  |  |
Agreements |  |  |  |
Royalties entity has right to receive (as a percent) | 2.50% |  |  |
Royalty Purchase Agreement | Dare | Sildenafil Cream |  |  |  |
Agreements |  |  |  |
Royalties entity has right to receive (as a percent) | 2.00% |  |  |
Royalty Purchase Agreement | Dare | Sildenafil Cream | Upon achievement of a pre-specified return threshold |  |  |  |
Agreements |  |  |  |
Royalties entity has right to receive (as a percent) | 1.25% |  |  |

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13 + Details
Name: | us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Royalty and commercial payment receivables probable and reasonably estimable to be received after one year or beyond the normal operating cycle, if longer. + References No definition available. + Details
Name: | xoma_LongTermRightsReceivableNonCurrent
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of milestone payment for each successive specified amount received. Contingent consideration is recognized under ASC 450 if it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. + References No definition available. + Details
Name: | xoma_PayableOnMilestone
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Return threshold for determining milestone payments under the agreement. + References No definition available. + Details
Name: | xoma_PayableOnMilestoneReturnThreshold
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Specified amount of each successive receipt that requires milestone payment to counterparty under agreement. + References No definition available. + Details
Name: | xoma_PayableOnMilestoneSpecifiedAmountOfEachSuccessiveReceipt
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of cash outflow for consideration under agreements, including Royalty Purchase Agreements (RPAs), Assignment and Assumption Agreements (AAAs), Commercial payment purchase agreement (CPPAs) and other agreements classified as investing activities. Payments may include upfront payments, one-time payments, milestone payments and contingent consideration payments. + References No definition available. + Details
Name: | xoma_PaymentOfConsiderationUnderAgreementsInvestingActivities
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of cash inflow under agreements, including Royalty Purchase Agreements (RPAs), Assignment and Assumption Agreements (AAAs), and Commercial Payment Purchase Agreements (CPPAs), classified as investing activities. Receipts may represent commercial payments attributable to net sales. + References No definition available. + Details
Name: | xoma_ReceiptsUnderAgreementsInvestingActivities
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Royalty and commercial payment receivables probable and reasonably estimable to be received within one year or the normal operating cycle, if longer. + References No definition available. + Details
Name: | xoma_RightsReceivableCurrent
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Percentage of royalties applicable under terms of agreement. + References No definition available. + Details
Name: | xoma_RoyaltyPercentageApplicableUnderAgreement
Namespace Prefix: | xoma_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalties entity has the right to receive as a percentage of net sales. + References No definition available. + Details
Name: | xoma_RoyaltyReceivablePercentageOnNetSales
Namespace Prefix: | xoma_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=xoma_RoyaltyPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=xoma_DareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=xoma_OvapreneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=xoma_ScenarioOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=xoma_SildenafilCreamMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |